Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts.
There are currently no clinical strategies utilizing tumor gene expression to inform therapeutic selection for patients with head and neck squamous cell carcinoma (HNSCC). One of the challenges in developing predictive biomarkers is the limited characterization of preclinical HNSCC models. Patient-d...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0282177 |
| _version_ | 1797843016191311872 |
|---|---|
| author | Rex H Lee Ritu Roy Hua Li Aaron Hechmer Tian Ran Zhu Adila Izgutdina Adam B Olshen Daniel E Johnson Jennifer R Grandis |
| author_facet | Rex H Lee Ritu Roy Hua Li Aaron Hechmer Tian Ran Zhu Adila Izgutdina Adam B Olshen Daniel E Johnson Jennifer R Grandis |
| author_sort | Rex H Lee |
| collection | DOAJ |
| description | There are currently no clinical strategies utilizing tumor gene expression to inform therapeutic selection for patients with head and neck squamous cell carcinoma (HNSCC). One of the challenges in developing predictive biomarkers is the limited characterization of preclinical HNSCC models. Patient-derived xenografts (PDXs) are increasingly recognized as translationally relevant preclinical avatars for human tumors; however, the overall transcriptomic concordance of HNSCC PDXs with primary human HNSCC is understudied, especially in human papillomavirus-associated (HPV+) disease. Here, we characterized 64 HNSCC PDXs (16 HPV+ and 48 HPV-) at the transcriptomic level using RNA-sequencing. The range of human-specific reads per PDX varied from 64.6%-96.5%, with a comparison of the most differentially expressed genes before and after removal of mouse transcripts revealing no significant benefit to filtering out mouse mRNA reads in this cohort. We demonstrate that four previously established HNSCC molecular subtypes found in The Cancer Genome Atlas (TCGA) are also clearly recapitulated in HNSCC PDXs. Unsupervised hierarchical clustering yielded a striking natural division of HNSCC PDXs by HPV status, with C19orf57 (BRME1), a gene previously correlated with positive response to cisplatin in cervical cancer, among the most significantly differentially expressed genes between HPV+ and HPV- PDXs. In vivo experiments demonstrated a possible relationship between increased C19orf57 expression and superior anti-tumor responses of PDXs to cisplatin, which should be investigated further. These findings highlight the value of PDXs as models for HPV+ and HPV- HNSCC, providing a resource for future discovery of predictive biomarkers to guide treatment selection in HNSCC. |
| first_indexed | 2024-04-09T16:57:38Z |
| format | Article |
| id | doaj.art-fa3559997291406bb9588f7dfd366b8e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-09T16:57:38Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-fa3559997291406bb9588f7dfd366b8e2023-04-21T05:35:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01183e028217710.1371/journal.pone.0282177Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts.Rex H LeeRitu RoyHua LiAaron HechmerTian Ran ZhuAdila IzgutdinaAdam B OlshenDaniel E JohnsonJennifer R GrandisThere are currently no clinical strategies utilizing tumor gene expression to inform therapeutic selection for patients with head and neck squamous cell carcinoma (HNSCC). One of the challenges in developing predictive biomarkers is the limited characterization of preclinical HNSCC models. Patient-derived xenografts (PDXs) are increasingly recognized as translationally relevant preclinical avatars for human tumors; however, the overall transcriptomic concordance of HNSCC PDXs with primary human HNSCC is understudied, especially in human papillomavirus-associated (HPV+) disease. Here, we characterized 64 HNSCC PDXs (16 HPV+ and 48 HPV-) at the transcriptomic level using RNA-sequencing. The range of human-specific reads per PDX varied from 64.6%-96.5%, with a comparison of the most differentially expressed genes before and after removal of mouse transcripts revealing no significant benefit to filtering out mouse mRNA reads in this cohort. We demonstrate that four previously established HNSCC molecular subtypes found in The Cancer Genome Atlas (TCGA) are also clearly recapitulated in HNSCC PDXs. Unsupervised hierarchical clustering yielded a striking natural division of HNSCC PDXs by HPV status, with C19orf57 (BRME1), a gene previously correlated with positive response to cisplatin in cervical cancer, among the most significantly differentially expressed genes between HPV+ and HPV- PDXs. In vivo experiments demonstrated a possible relationship between increased C19orf57 expression and superior anti-tumor responses of PDXs to cisplatin, which should be investigated further. These findings highlight the value of PDXs as models for HPV+ and HPV- HNSCC, providing a resource for future discovery of predictive biomarkers to guide treatment selection in HNSCC.https://doi.org/10.1371/journal.pone.0282177 |
| spellingShingle | Rex H Lee Ritu Roy Hua Li Aaron Hechmer Tian Ran Zhu Adila Izgutdina Adam B Olshen Daniel E Johnson Jennifer R Grandis Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. PLoS ONE |
| title | Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. |
| title_full | Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. |
| title_fullStr | Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. |
| title_full_unstemmed | Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. |
| title_short | Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. |
| title_sort | therapeutic implications of transcriptomics in head and neck cancer patient derived xenografts |
| url | https://doi.org/10.1371/journal.pone.0282177 |
| work_keys_str_mv | AT rexhlee therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT rituroy therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT huali therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT aaronhechmer therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT tianranzhu therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT adilaizgutdina therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT adambolshen therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT danielejohnson therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts AT jenniferrgrandis therapeuticimplicationsoftranscriptomicsinheadandneckcancerpatientderivedxenografts |